UnitedHealth Group stock returns 11.72% over 20 years

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

UnitedHealth Group delivered an 11.72% average annual return over the last 20 years, outpacing the market by 2.46% annually. A $100 investment made two decades ago would now be worth $929.67, reflecting the power of compounded growth.

powered bylight_fuzz_icon
44387073

*this image is generated using AI for illustrative purposes only.

UnitedHealth Group has generated an average annual return of 11.72% over the past 20 years, outperforming the market by 2.46% on an annualized basis. This performance highlights the impact of compounded returns on long-term investment growth. The company currently maintains a market capitalization of $378.53 billion.

An investor who purchased $100 worth of UnitedHealth Group stock two decades ago would see that investment grow to $929.67 today. This calculation is based on a current share price of $416.82. The significant appreciation underscores the value of sustained holding periods in equities.

Performance Overview

The following table details the key financial metrics related to UnitedHealth Group's long-term performance:

Metric Value
Average Annual Return 11.72%
Market Outperformance vs. Market 2.46%
Current Market Capitalization $378.53 billion
Growth of $100 Investment (20 Years) $929.67
Current Share Price $416.82

The primary insight from this data is the substantial effect that compounded returns can have on cash growth over extended periods. While past performance does not guarantee future results, the historical data illustrates the potential for wealth accumulation through consistent market participation.

What factors could influence UnitedHealth Group's ability to maintain its historical outperformance in the next decade?

How might regulatory changes in the healthcare sector impact UnitedHealth Group's future growth trajectory?

What are the potential risks to UnitedHealth Group's market capitalization given its current valuation?

like19
dislike

Leerink Partners raises UnitedHealth target to $462

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Leerink Partners analyst Whit Mayo maintained an Outperform rating on UnitedHealth Group and raised the price target to $462 from $400.

powered bylight_fuzz_icon
43256941

*this image is generated using AI for illustrative purposes only.

Leerink Partners analyst Whit Mayo has maintained an Outperform rating on UnitedHealth Group while raising the stock's price target to $462 from $400. The adjustment reflects a revised valuation outlook for the healthcare giant.

Rating and Price Target

The research note reinforces a positive stance on UnitedHealth Group's shares. Below are the updated details:

Metric Value
Rating Outperform
Previous Price Target $400
New Price Target $462

The new target represents a significant increase from the prior level.

What specific factors drove Leerink Partners to revise their valuation outlook for UnitedHealth Group?

How might this price target increase influence other analysts' ratings on UnitedHealth Group?

What are the potential risks that could prevent UnitedHealth Group from reaching the new $462 price target?

like20
dislike

More News on UnitedHealth Group Inc